ZeroStack Corp. (ZSTK): Nasdaq/NYSE listing notice — Flora Growth board loses independent director majority after passing of Harold Wolkin

ZeroStack Corp.

Director Harold Wolkin passed away August 25, 2025; he served on audit, compensation, and nominating committees.
Board now has four members, only two independent, violating Nasdaq Rule 5605(b)(1) requiring majority independent directors.
Audit committee now has two independent members, violating Nasdaq Rule 5605(c)(2)(A) requiring at least three.
Company has cure period until August 25, 2026 or next annual meeting to regain compliance with Nasdaq governance rules.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

ZeroStack Corp. received a nasdaq deficiency notice notice regarding board independence (rules 5605(b)(1), 5605(c)(2)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: board independence
Rules: 5605(b)(1), 5605(c)(2)(A)

Exact text from the filing

August 26, 2025, Nasdaq was informed that because of Mr. Wolkin's passing, the Company is no longer in compliance with certain Corporate Governance Requirements as set forth in Nasdaq Listing Rule 5605. Pursuant to Nasdaq Listing Rule 5605(b)(1), a majority of the Board of a listed company must be comprised of Independent Directors. With Mr. Wolkin's passing, the Board is currently comprised of only four members, Sammy Dorf, Clifford Starke, Edward Woo and Manfred Leventhal. Only two of the four, Mr. Woo and Mr. Leventhal, qualify as Independent Directors. Therefore, the Company's Board is no

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ZeroStack Corp. filing history →

Source: SEC EDGAR

accession 0001062993-25-015011

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.